Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

Key Points

• Cyclin D1 rearrangements are significant markers in diffuse large B-cell lymphoma, indicating a distinct biological behavior.
• Among affected individuals, those with cyclin D1 alterations show unique clinical features, which could alter treatment approaches.
• Analysis focused on genomic rearrangements and their implications on proliferation pathways, influencing therapy choices.
• Highlights the growing importance of cyclin D1 as a biomarker, indicating a need for enhanced diagnostic methods.